Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Fixed Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.500.420.480.360.36

What is the latest Fixed Capital/Sales ratio of NGL FINECHEM ?

The latest Fixed Capital/Sales ratio of NGL FINECHEM is 0.50 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.50
Mar20240.42
Mar20230.48
Mar20220.36
Mar20210.36

How is Fixed Capital/Sales of NGL FINECHEM Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.5
19.05
Mar2024 0.42
-12.50
Mar2023 0.48
33.33
Mar2022 0.36
0.00
Mar2021 0.36 -

Other Financial Ratios of NGL FINECHEM


Compare Fixed Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹796.6 Cr 5.5% 4.3% -49.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,731.0 Cr -4.1% -2.1% -5.1% Stock Analytics
DIVIS LABORATORIES ₹172,373.0 Cr -2.8% -5.9% 29.2% Stock Analytics
CIPLA ₹122,411.0 Cr -3.7% 0.1% -2.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,285.0 Cr -4.1% 7.3% 14.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,270.0 Cr -5.7% -6.1% -11.6% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

5.5%

4.3%

-49.8%

SENSEX

0.2%

-2.7%

-0.9%


You may also like the below Video Courses